Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 2,000 shares, a decrease of 28.6% from the January 31st total of 2,800 shares. Based on an average trading volume of 700 shares, the days-to-cover ratio is presently 2.9 days.

Hikma Pharmaceuticals Price Performance

OTCMKTS HKMPY remained flat at $54.80 on Tuesday. 320 shares of the company traded hands, compared to its average volume of 849. The stock’s 50 day moving average is $53.89 and its two-hundred day moving average is $51.61. Hikma Pharmaceuticals has a fifty-two week low of $46.16 and a fifty-two week high of $59.26.

Hikma Pharmaceuticals Increases Dividend

The company also recently announced a dividend, which will be paid on Monday, May 12th. Investors of record on Friday, March 21st will be given a $0.94 dividend. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.62. The ex-dividend date is Friday, March 21st. Hikma Pharmaceuticals’s payout ratio is presently 10.34%.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.